Takashi Kei Kishimoto

2021

In 2021, Takashi Kei Kishimoto earned a total compensation of $1.3M as Chief Scientific Officer at SELECTA BIOSCIENCES, a 62% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$160,000
Option Awards$526,588
Salary$399,798
Stock Awards$214,133
Other$6,156
Total$1,306,675

Kishimoto received $526.6K in option awards, accounting for 40% of the total pay in 2021.

Kishimoto also received $160K in non-equity incentive plan, $399.8K in salary, $214.1K in stock awards and $6.2K in other compensation.

Rankings

In 2021, Takashi Kei Kishimoto's compensation ranked 7,800th out of 12,415 executives tracked by ExecPay. In other words, Kishimoto earned more than 37.2% of executives.

ClassificationRankingPercentile
All
7,800
out of 12,415
37th
Division
Manufacturing
3,443
out of 5,505
38th
Major group
Chemicals And Allied Products
1,533
out of 2,375
36th
Industry group
Drugs
1,362
out of 2,096
35th
Industry
Pharmaceutical Preparations
1,006
out of 1,546
35th
Source: SEC filing on May 3, 2022.

Kishimoto's colleagues

We found six more compensation records of executives who worked with Takashi Kei Kishimoto at SELECTA BIOSCIENCES in 2021.

2021

Carsten Brunn

SELECTA BIOSCIENCES

Chief Executive Officer

2021

Kevin Tan

SELECTA BIOSCIENCES

Chief Financial Officer

2021

Peter Traber

SELECTA BIOSCIENCES

Chief Medical Officer

2021

Lloyd Johnston

SELECTA BIOSCIENCES

Chief Operations Officer

2021

Bradford Dahms

SELECTA BIOSCIENCES

Chief Financial Officer

2021

Ann Donohue

SELECTA BIOSCIENCES

VP, Finance and Corporate Controller, Principal Financial and Accounting Officer

News

You may also like